COVID-19 pandemic accelerated adoption of shorter, lower-burden (lower cost) breast radiation therapy

The COVID-19 pandemic accelerated the adoption of shorter-course radiation therapy for women with early-stage breast cancer, leading to reduced treatment burden and lower health care spending, according to a new study published in the American Journal of Clinical Oncology.

≈